|
|
||||||||||||||
|
|
|||||||||||||||
LETTER |
1 Division of Neurology, Nelson R Mandela School of Medicine, University of Natal, Durban, South Africa
2 Biostatistics, Medical Research Council, Durban, South Africa
Correspondence to:
Correspondence to:
Dr VB Patel, Department of Neurology, Ward A3, Wentworth Hospital, Private Bag Jacobs, Durban 4026, South Africa;
patelv@nu.ac.za
Keywords: human immunodeficiency virus; cytokines; tuberculous meningitis
| The first 150 words of the full text of this article appear below. |
The immunological response in pulmonary and pleural tuberculosis has been extensively studied. However, the response in tuberculous meningitis has not been well documented.1 In pulmonary disease, exposure to tuberculous antigens results in a T cell and natural killer cellular response, elaborating various cytokines, mainly of T helper type 1 (Th1) origin. Stimulated macrophages elaborate tumour necrosis factor (TNF)
, interleukin (IL) 12, and IL 1, promoting further recruitment and activation of macrophages and lymphocytes.
TNF
correlates with disease severity and may contribute to tissue necrosis; however, TNF
has also contributed to survival in mouse studies.2 Transforming growth factor ß (Th3 cytokine) suppresses macrophage activation. IL 2 may be beneficial in promoting an immune response in HIV seropositive patients. Th1 and Th2 cytokine responses have been observed in cerebrospinal fluid (CSF) of HIV seronegative patients with tuberculous meningitis.3,4. Whether the response is similar in HIV seropositive patients with tuberculous meningitis
This article has been cited by other articles:
![]() |
V. Patel, A. Bhigjee, P. Bill, and C. Connolly Cytokine profiles in HIV seropositive patients with tuberculous meningitis Sex. Transm. Inf., February 1, 2003; 79(1): 75 - 76. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |